Sector Chart Enveric Biosciences, Inc.

Equities

ENVB

US29405E5050

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2026-02-13 pm EST			5-day change	1st Jan Change
2.100 ^USD	+3.96%		-11.39%	-42.15%

Jan. 29	Enveric Biosciences, Inc. Expands Collaboration with TOTEC Pharma Through Trademark License and Option	CI
Jan. 28	Enveric Biosciences announces closing of $1.5 million registered direct offering priced at-the-market under Nasdaq rules	RE

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales growth	Profitability	Finances	EV / Sales	P/E
ENVERIC BIOSCIENCES, INC.	2.92M	-	-	-	-	-
LONZA GROUP AG	47.61B
BEONE MEDICINES AG	38.3B
CELLTRION, INC.	36.11B
IQVIA HOLDINGS INC.	28.31B
REVOLUTION MEDICINES, INC.	18.62B	-	-	-	-	-